Elanco Animal Health Inc ELAN Balance Sheet

Elanco animal health inc (ELAN)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Dec'17
Assets
Current Assets
Cash and cash equivalents
1,206	334	309	385	272	474	300	323
Accounts receivable, net of allowances of $7.4 (2020) and $6.2 (2019)
676	816	758	757	684	651	606	567
Other receivables
66	73	65	74	107	57	30	34
Inventories (Note 8)
1,019	1,050	1,068	1,053	1,035	1,004	1,008	1,062
Prepaid expenses and other
132	87	98	102	114	113	123	136
Receivable from Lilly (Note 16)
8	0	-	-	35	-	-	-
Restricted cash (Note 16)
10	11	11	11	28	202	634	0
Total current assets
3,120	2,373	2,310	2,383	2,278	2,504	2,703	2,123
Noncurrent Assets
Investments (Note 10)
-	-	-	-	-	-	14	12
Goodwill
3,004	2,989	2,946	2,959	2,933	3,000	2,968	2,969
Other intangibles, net
2,455	2,482	2,435	2,352	2,386	2,504	2,514	2,672
Other noncurrent assets
217	185	220	229	219	66	100	242
Property and equipment, net of accumulated depreciation of $919.7 (2020) and $930.5 (2019)
930	955	911	931	930	922	909	920
Total assets
9,727	8,985	8,823	8,856	8,747	8,956	9,211	8,940
Liabilities and Equity
Current Liabilities
Accounts payable
215	222	206	242	252	205	202	203
Employee compensation
56	99	88	67	64	98	81	89
Sales rebates and discounts
192	211	182	176	171	169	147	165
Current portion of long-term debt (Note 10)
26	24	24	27	29	29	-	0
Other current liabilities
217	244	181	205	191	199	178	184
Payable to Lilly (Note 16)
0	16	-	-	-	-	-	-
Payable to Lilly (Note 20)
-	-	58	58	0	268	634	0
Total current liabilities
707	818	741	777	708	970	1,245	643
Noncurrent Liabilities
Long-term debt (Note 10)
2,035	2,330	2,335	2,382	2,436	2,443	2,478	0
Accrued retirement benefits
82	82	81	108	106	109	136	139
Deferred taxes
90	100	81	147	131	114	125	251
Other noncurrent liabilities
150	106	96	175	168	121	89	126
Total liabilities
3,065	3,438	3,336	3,591	3,551	3,759	4,074	1,160
Commitments and Contingencies (Note 13)
0	0	0	0	0	-	0	-
Equity
Preferred stock, no par value, 1,000,000,000 shares authorized; none issued
0	0	-	-	-	0	-	-
Net parent company investment
-	-	-	-	-	-	0	8,036
Common stock, no par value, 5,000,000,000 shares authorized, 398,825,969 and 373,011,513 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively
0	0	0	0	0	0	0	0
Additional paid-in capital
6,870	5,636	5,646	5,396	5,398	5,403	5,347	0
Retained earnings
33	84	93	83	47	16	-	0
Accumulated other comprehensive loss
-242	-173	-252	-214	-250	-222	-210	-256
Total equity
6,661	5,546	5,487	5,265	5,196	5,197	5,137	7,780
Total liabilities and equity
9,727	8,985	8,823	8,856	8,747	8,956	9,211	8,940